![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, December 26, 2012 10:55:29 PM
12/069,807 – 47 Protein Biomarkers for Neurodegenerative Diseases
http://www.katiecouric.com/on-the-show/2012/12/26/michael-j-fox-dec-26-2012/
This is game changing. The day MJF goes on a mass media outlet and refers directly to a test for Parkinson's , AMBS secures the pattens for such a test. Connect the dots people. 50 and 200 day crossover, rubinfield not only showing up in person to the ambs presentation of data but then giving his own presentation on the profitability of ambs products. Room to run , open pastures. 100 and 200 ma crossover on the horizon.
Things to come.
The 8th, what a day that will be
The MJF full backing press release, what a day
and then primate testing and serious money.
And by the way all this might become even more exponential if ambs follows through and files for anorphan drug.
imo,
fmarca1
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM